
Welartan-M 50 Tablet ER
Marketer
Delcure Life Sciences
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Welartan-M 50 Tablet ER
Epanol 50mg Extended-Release Tablets are prescribed to manage hypertension. Lowering blood pressure reduces the risk of future strokes and heart attacks; early use improves heart attack survival rates. For consistent blood levels, take Epanol 50mg ER with food daily at the same time, continuing treatment as your physician directs. Do not discontinue the medication independently, even if feeling well, as hypertension is often asymptomatic; abrupt cessation may worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further support blood pressure control. Strictly adhere to your doctor's instructions. Potential side effects include headache, weakness, lightheadedness, hypotension, hyperkalemia, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving or operate machinery, and rise slowly from a seated position. Regular monitoring of blood pressure, blood glucose, kidney function, urea, and electrolytes may be required. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. Pregnant or breastfeeding individuals must consult their doctor prior to use. Always disclose all other medications, especially those for hypertension or cardiac issues.
Uses of Welartan-M 50 Tablet ER
Managing elevated blood pressure
Major Benefits of Welartan-M 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Welartan-M 50 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Welartan-M 50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Welartan-M 50 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Welartan-M 50 Tablet ER with a meal.
How Welartan-M 50 Tablet ER works:
Welartan-M 50 Extended-Release tablets contain a dual-action formulation of telmisartan and metoprolol succinate, both agents effective in reducing blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Welartan-M 50 Tablet ER and alcohol is contraindicated due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Welartan-M 50 Tablet ER is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Welartan-M 50mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Welartan-M 50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Welartan-M 50 Tablet ER without requiring a dosage change.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Welartan-M 50 ER tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Welartan-M 50 Tablet ER :
Should you forget a dose of Welartan-M 50 Tablet ER, take it immediately if you remember. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Welartan-M 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
